The Vena Cava Clips and Filters Market is expected to grow at a CAGR of 5.8% from 2024 to 2031. According to estimates, the market will grow from XX USD in 2024 to YY USD by 2031. North America now dominates the market, accounting for the vast majority of worldwide sales. Key criteria include rising rates of deep vein thrombosis (DVT) and pulmonary embolism (PE), an ageing population, and technological advances in filter design.
The market is growing steadily, owing to an increase in the global incidence of venous thromboembolism (VTE). Sedentary lifestyles, obesity, and the increase in surgical procedures all contribute to the growing patient population. Furthermore, the development of new retrievable filters with higher safety profiles is driving market growth.
Market Trend: shift towards retrievable vena cava filters due to long-term safety concerns
The vena cava clips and filters market is seeing a considerable shift towards the use of retrievable filters over permanent ones. Growing worries about the long-term safety and difficulties associated with permanent filters are driving this move. Retrievable filters provide temporary protection from pulmonary embolism while allowing for removal once the risk has passed.
Retrieveable filters are becoming increasingly popular among healthcare practitioners due to their versatility in patient management. These devices can be left in place for lengthy periods of time or removed when no longer required, lowering the risk of long-term problems such as filter fracture, migration, or inferior vena cava perforation. Guidelines from professional associations support the trend, advising the use of retrievable filters and their early removal when clinically appropriate.
Furthermore, advances in filter design and retrieval procedures have increased the success rate of filter removal, even after long implantation times. This has enhanced physicians' trust in employing retrievable filters, resulting in a greater market share. The trend is likely to continue as more healthcare facilities employ filter installation and retrieval techniques, providing better patient outcomes and lowering the risk of filter-related problems.
Market Driver: Increasing prevalence of venous thromboembolism (VTE) and related risk factors
The increasing prevalence of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major driver of the vena cava clips and filters industry. VTE is a major global health concern, impacting millions of people and leading to high morbidity and mortality rates.
Recent epidemiological data estimate the annual incidence of VTE to be 1-2 per 1,000 people in the general population, with rates growing exponentially with age. Every year, VTE affects an estimated 900,000 persons in the United States, resulting in around 100,000 deaths. Obesity, cancer, and major surgical operations are all becoming increasingly common risk factors for VTE.
For example, the global prevalence of obesity has nearly quadrupled since 1975, with more than 650 million persons classed obese in 2016. This considerable increase in obesity rates is directly related to a higher risk of VTE, boosting demand for preventive interventions such as vena cava filters. Furthermore, the increasing ageing population, which is more vulnerable to VTE, drives market expansion. In 2019, there were an estimated 703 million people aged 65 and up worldwide, with the number expected to treble to 1.5 billion by 2050.
The growing awareness among healthcare practitioners of the importance of VTE prevention and management has resulted in more aggressive screening and treatment methods, including the use of vena cava filters in high-risk patients. This tendency is projected to continue to drive market expansion during the forecast period.
Market Restraint: Complications and recalls associated with vena cava filters
Despite the advantages of vena cava filters in preventing pulmonary embolism, worries about risks and product recalls limit market growth. Reports of adverse events linked to these devices have prompted heightened scrutiny from regulatory organisations and healthcare practitioners.
A study published in the Journal of Vascular Surgery discovered that the total complication rate for inferior vena cava filters was around 14%. Common consequences include filter migration, fracture, and inferior vena cava perforation. These difficulties have resulted in product recalls and safety warnings, affecting market confidence.
Retrievable filters dominate the vena cava clips and filters market, accounting for the largest market share.
The retrievable filter sector has emerged as the leading force in the vena cava clips and filters market, owing to its versatility and superior safety profile when compared to permanent filters. These devices provide temporary protection against pulmonary embolism while enabling removal once the risk has passed, answering concerns about long-term problems from permanent filter installation.
Recent data from a multi-centre study of 952 patients showed that retrievable filters had an 87% success rate when done within the required timeframe. Healthcare professionals have increased adoption as a result of the high success rate and fewer long-term problems. The study also found a considerable reduction in filter-related adverse events, with only 2.8% of patients having difficulties, compared to previous rates of up to 10% for permanent filters.
Furthermore, technical improvements have increased the popularity of retrievable filters. For example, the advent of novel filter designs with improved retrievability features has increased the time frame for safe removal. A recent breakthrough by a major medical device manufacturer has resulted in a filter that can be securely retrieved up to 12 months after implantation, a significant advance above earlier models that only lasted 3-6 months.
The hospital segment dominates the vena cava clips and filters market, owing to the rising frequency of VTE-related hospitalisations and the difficulty of filter placement procedures. According to recent healthcare utilisation data, hospitals account for more than 70% of vena cava filter placements, with the rest split between ambulatory surgical centres and speciality clinics.
A statewide survey of hospital admissions indicated that VTE-related hospitalisations have grown by 12% in the last five years, with a similar increase in filter implantation. This tendency is especially noticeable in large urban hospitals and academic medical centres, which frequently manage difficult cases and high-risk patients.
Furthermore, the increased adoption of specialised vascular intervention units inside hospital settings reinforces the hospital segment's dominance. These dedicated units, which are manned by interventional radiologists and vascular surgeons, have been demonstrated to enhance filter placement results and efficiency. According to a recent study in the Journal of Vascular and Interventional Radiology, hospitals with specialised vascular units achieved a 95% technical success rate in filter insertion, compared to 88% in general interventional suites.
North America dominates the vena cava clips and filters market, holding the largest market share globally.
Several reasons contribute to North America's dominance in the vena cava clips and filters industry, including a high prevalence of venous thromboembolism (VTE), advanced healthcare infrastructure, and early acceptance of novel medical technologies. The region has constantly led in the development and use of vena cava filters.
Recent epidemiological data show that the United States has one of the highest incidence rates of VTE in the world with an estimated 90,000 cases per year. This high illness load has created a substantial demand for preventive interventions, such as vena cava filters. Furthermore, the existence of important market competitors and a favourable reimbursement environment have contributed to the region's market supremacy.
The North American market has also been a leader in the use of superior retrievable filter technologies. A recent market analysis revealed that retrievable filters currently account for more than 75% of all filter placements in the region, indicating a shift towards more flexible treatment alternatives.
The United States tops the world in healthcare spending, accounting for over 17% of its GDP. This enormous investment has permitted the broad use of modern medical devices, such as vena cava filters, throughout healthcare organisations.
Canada has also made a substantial contribution to the region's market share, with an increasing emphasis on VTE prevention in the healthcare system. Recent initiatives by the Canadian Patient Safety Institute have resulted in increasing awareness and use of VTE prevention procedures, including the use of vena cava filters in high-risk patients.
The regulatory structure in North America, notably the FDA's severe oversight, has had a significant impact on market development. The FDA's active monitoring and advising on the use of vena cava filters have resulted in better product safety and efficacy, which has fuelled market growth.
Recent advancements in the region include the establishment of specialised vascular centres of excellence in key cities. These centres have reported a 30% increase in the volume of difficult vena cava filter surgeries in the last two years, demonstrating the region's increased capabilities in managing high-risk VTE patients.
The market for vena cava clips and filters is fiercely competitive, with prominent competitors vying for market dominance through innovation. Market leaders have gained a firm presence through diverse product portfolios, effective distribution networks, and strategic partnerships with healthcare providers.
A financial study shows that the top five firms account for almost 65% of the global market share. These companies have shown sustained revenue growth, with an average yearly increase of 6-8% over the last three years. Leading corporations invest between 8 and 12% of their yearly revenues in research and development, demonstrating the industry's emphasis on innovation.
Recent market trends show a shift towards the development of enhanced retrievable filters with longer implantation times and higher safety profiles. Several important firms have introduced next-generation filters that improve retrievability and lower complication rates. For example, a prominent medical equipment firm recently released a filter with a revolutionary retrieval mechanism, which achieved a 98% success rate in clinical trials.
Mergers and acquisitions have significantly influenced the competitive landscape. Two noteworthy purchases occurred in the last year, both of which attempted to extend product portfolios and geographical reach. These strategic decisions have allowed corporations to strengthen their market positions and gain access to new technologies.
Partnerships between academic institutions and healthcare providers for clinical research and product development are becoming more widespread. These collaborations have resulted in the publishing of multiple high-impact studies, bolstering the scientific case for filter use in high-risk patient populations.
Looking ahead, the competitive focus will move to the development of bioabsorbable filters and smart filters with remote monitoring capabilities. Early-stage research in these areas indicates that considerable market disruption may occur in the future years.
The market for vena cava clips and filters is expected to develop steadily, owing to rising venous thromboembolism rates and an ageing population. However, the market faces obstacles, as worries about long-term consequences and product recalls continue to influence clinical practice and regulatory control.
An exciting trend to watch is the potential shift towards pharmaceutical options and better prophylactic measures, which may affect the amount of filter implantation in specific patient populations. Healthcare practitioners are increasingly using risk stratification methods to identify patients who will benefit the most from filter insertion, which could lead to more targeted usage of these devices.
Furthermore, the creation of bioabsorbable filters is a promising frontier in the research. These novel technologies, which are now in early clinical studies, have the potential to alleviate many of the issues associated with long-term filter implantation. If successful, bioabsorbable filters could drastically alter the market landscape in the second half of the forecast period.
Boston Scientific Corporation
Cook Medical
Medtronic plc
Cardinal Health
B. Braun Melsungen AG
Terumo Corporation
Cordis (Cardinal Health)
Argon Medical Devices, Inc.
Koninklijke Philips N.V.
Abbott Laboratories
June 2023: A leading medical device company received FDA clearance for its next-generation retrievable vena cava filter, featuring an extended retrieval window of up to 12 months.
March 2023: A major player in the market announced a strategic partnership with a healthcare AI company to develop smart filters with real-time monitoring capabilities.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Boston Scientific Corporation
5.2. Cook Medical
5.3. Medtronic plc
5.4. Cardinal Health
5.5. B. Braun Melsungen AG
5.6. Terumo Corporation
5.7. Cordis (Cardinal Health)
5.8. Argon Medical Devices, Inc.
5.9. Koninklijke Philips N.V.
5.10. Abbott Laboratories (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards retrievable vena cava filters due to long-term safety concerns
6.1.2. Development of bioabsorbable filters
6.1.3. Integration of smart technology in filter design
6.2. Market Drivers
6.2.1. Increasing prevalence of venous thromboembolism (VTE) and related risk factors
6.2.2. Growing aging population susceptible to VTE
6.2.3. Advancements in filter design and retrieval techniques
6.3. Market Restraints
6.3.1. Complications and recalls associated with vena cava filters
6.3.2. Increasing adoption of alternative VTE prevention methods
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Permanent Filters
7.2. Retrievable Filters
7.2.1. Conical Filters
7.2.2. Cylindrical Filters
8. BY MATERIAL (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH)--2020-2031)
8.1. Stainless Steel
8.2. Nitinol
8.3. Others
8.3.1. Titanium
8.3.2. Cobalt-Chromium Alloys
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.1.1. General Hospitals
9.1.2. Speciality Hospitals
9.2. Ambulatory Surgical Centres
9.3. Speciality Clinics
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%, YOY GROWTH)--2020-2031.
By Product Type:
Permanent Filters
Retrievable Filters
By Material:
Stainless Steel
Nitinol
Others
By End User:
Hospitals
Ambulatory Surgical Centres
Speciality Clinics
By Region:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511
